Global data support RAB32 gene mutation’s link to Parkinson’s

A mutation in the RAB32 gene, previously linked to Parkinson’s disease, was found to be over 100 times more common in Parkinson’s patients than in the general population, according to the Rostock International Parkinson’s Disease study. This international study, launched by Centogene in 2018, aims to better understand Parkinson’s by examining its genetic components. The mutation, Ser71Arg, was found in 0.3% of Parkinson’s patients but only 0.002% of the general population, highlighting a strong connection. Interestingly, 78% of those with the mutation were women, though their age of onset remained similar to others with the disease. Researchers also suggest this mutation might trace back to a common ancestor. This study underscores the importance of genetics in Parkinson’s and suggests incorporating genetic testing into standard care. Centogene’s ROPAD Consortium is furthering these efforts by accelerating research and improving treatment options for Parkinson’s patients.